INmune Bio, Inc. (INMB)
NASDAQ: INMB · IEX Real-Time Price · USD
8.07
-0.35 (-4.16%)
Jul 2, 2024, 4:00 PM EDT - Market closed
INmune Bio Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for INmune Bio.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for INmune Bio.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $16 | Buy | Initiates | $16 | +98.27% | Jun 1, 2023 |
| BTIG | BTIG | Strong Buy Maintains $31 → $14 | Strong Buy | Maintains | $31 → $14 | +73.48% | May 24, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $14 → $7 | Strong Buy → Hold | Downgrades | $14 → $7 | -13.26% | May 24, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $32 → $20 | Strong Buy | Maintains | $32 → $20 | +147.83% | Jan 24, 2022 |
| BTIG | BTIG | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 1, 2020 |
Financial Forecast
Revenue This Year
29.92K
from 155.00K
Decreased by -80.70%
Revenue Next Year
30.60K
from 29.92K
Increased by 2.28%
EPS This Year
-2.74
from -1.67
EPS Next Year
-2.61
from -2.74
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 63,000 | 63,000 | 63,000 | 192.0M | 318.1M |
| Avg | 29,917 | 30,600 | 30,600 | 93.3M | 163.5M |
| Low | 13,720 | n/a | n/a | 59,780 | 17.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -59.4% | 110.6% | 105.9% | 627,187.6% | 241.0% |
| Avg | -80.7% | 2.3% | - | 304,684.3% | 75.3% |
| Low | -91.1% | - | - | 95.4% | -81.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.60 | -2.56 | -2.32 | 5.03 | 10.13 |
| Avg | -2.74 | -2.61 | -2.50 | 1.39 | 4.15 |
| Low | -2.78 | -2.62 | -2.65 | -2.03 | -1.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 630.4% |
| Avg | - | - | - | - | 198.9% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.